JINGHUA PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.76 CNY | +0.65% |
|
+3.33% | -12.51% |
| 18/04 | Jinghua Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 18/04 | Jinghua Pharmaceutical's Unit Shuts Down Amid Water Pollution Probe | MT |
| Sales 2022 | 1.57B 217M 18.1B | Sales 2023 | 1.51B 209M 17.4B | Capitalization | 7.22B 997M 83.1B |
|---|---|---|---|---|---|
| Net income 2022 | 212M 29.26M 2.44B | Net income 2023 | 248M 34.23M 2.85B | EV / Sales 2022 | 5.59 x |
| Net cash position 2022 | 1.04B 143M 11.92B | Net cash position 2023 | 1.22B 168M 14B | EV / Sales 2023 | 3.97 x |
| P/E ratio 2022 |
46.3
x | P/E ratio 2023 |
29.2
x | Employees | 1,641 |
| Yield 2022 |
0.66% | Yield 2023 |
-
| Free-Float | 59.32% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.65% | ||
| 1 week | +3.33% | ||
| Current month | -1.77% | ||
| 1 month | -0.13% | ||
| 3 months | +0.13% | ||
| 6 months | -13.10% | ||
| Current year | -12.51% |
1 week
7.46
7.79
1 month
7.108.11
Current year
5.889.13
1 year
5.8811.00
3 years
4.4328.80
5 years
3.9628.80
10 years
3.4630.60
| Managers | Title | Age | Since |
|---|---|---|---|
Yun Zhong Zhou
CEO | Chief Executive Officer | 60 | 18/13/18 |
Yu Xiang Wu
DFI | Director of Finance/CFO | 55 | 08/21/08 |
Jian Qin
COO | Chief Operating Officer | 50 | 28/17/28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yun Zhong Zhou
CEO | Chief Executive Officer | 60 | 18/13/18 |
Qiao Gen Feng
BRD | Director/Board Member | 63 | 13/19/13 |
Hong Wei Xue
CHM | Chairman | 58 | 03/17/03 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 7.76 | +0.65% | 9,837,583 |
| 25/24/25 | 7.71 | +0.52% | 8,823,200 |
| 24/24/24 | 7.67 | +0.52% | 6,327,425 |
| 23/24/23 | 7.63 | +0.26% | 7,047,000 |
| 22/24/22 | 7.61 | +1.33% | 9,460,441 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes
JINGHUA PHARMACEUTICAL GROUP CO., LTD., formerly NANTONG JINGHUA PHARMACEUTICAL CO., LTD., is a China-based company, principally engaged in the research and development, production and distribution of Chinese patent drugs, pharm ingredients and intermediates and chemical intermediates. The Company is also engaged in the provision of traditional Chinese medicinal materials and Chinese herbal pieces, among others. The Company primarily provides tablets, capsules, pills, granules, injections, powder, syrup, healthcare products, beverages and chemical intermediates, among others. The Company offers Chinese patent medicines, such as Wangshi Baochiwan pills and Jidesheng tablets. Its bulk drugs include phenobarbitone and fluorouracil. The Company distributes its products in domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
30/04/2024
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -12.51% | 872M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 002349 Stock
